Notably, in FXR KO mice, the pharmacological effects of Gyps in HFD-induced NASH were significantly abrogated by the depletion of the FXR gene, suggesting a direct role of FXR in the Gyps-mediated effects. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.